Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
TeamHealth Holdings, Inc. to Present at Upcoming Investor Conferences
-
EFI to Present at the Canaccord 36th Annual Growth Conference
-
Atara Bio to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Endologix to Present at the 36th Annual Canaccord Genuity Growth Conference
-
Cubic to Participate in the Canaccord Genuity Growth Conference
-
Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016
-
Datalink Corporation to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Aldeyra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
-
SCYNEXIS, Inc. to Present at the Canaccord Genuity Growth Conference
-
IPG Photonics to Present at 36th Annual Canaccord Genuity Growth Conference
-
Guidance Software Announces Upcoming Conference Participation
-
Rubicon Project to Present at the Oppenheimer Technology, Internet & Communications Conference and the Canaccord Genuity Growth Conference
-
Versartis to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Exa Corporation to Present at the Canaccord Genuity Growth Conference
-
Abaxis, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Osprey Medical Announces Oversubscribed A$28 Million Private Placement
-
Aduro Biotech to Present at Canaccord Genuity Growth Conference
-
Lipocine to Present at 36th Annual Canaccord Genuity Growth Conference
-
MacroGenics to Participate in Two Upcoming Investor Conferences
-
Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference
-
Mitek to Present at the Canaccord Genuity Growth Conference
-
Akari Therapeutics to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Selecta Biosciences to Present at Canaccord Genuity Growth Conference
-
Radius Health Reports Second Quarter 2016 Financial and Operating Results
-
T2 Biosystems to Present at the Canaccord Genuity Growth Conference
-
Apricus Biosciences to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Sage Therapeutics to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Canaccord Genuity Group Inc. Reports First Quarter Fiscal 2017 Results
-
Zafgen to Present at Canaccord Genuity’s 36th Annual Growth Conference
-
Maxwell Announces Participation in Canaccord Genuity 36th Annual Growth Conference
-
Ecolab Schedules Webcast of Industry Conference for August 11, 2016
-
Steve Madden Announces Participation in the Canaccord Genuity Growth Conference
-
Kite Pharma to Present at the Canaccord Genuity 36th Annual Growth Conference
-
SPS Commerce Announces Schedule of Upcoming Investor Conferences
-
Veresen Announces Enhanced Funding Strategy Through Pursuing Sale of Power Business and the Suspension of DRIP, Second Quarter Financial Results and Increased Guidance
-
Reis, Inc. to Present at Canaccord Genuity’s Growth Conference 2016
-
MasTec Senior Management to Present at Investor Conferences in Boston and New York
-
Biothera Pharmaceuticals to Present at The Canaccord Genuity Growth Conference
-
Ultimate Announces Schedule of Investor Conferences for August 2016
-
Xylem Inc. to participate in the Canaccord Genuity, Inc. 36th Annual Growth Conference
-
SharpSpring to Present at Canaccord Genuity’s 36th Annual Growth Conference on August 11, 2016
-
MeetMe to Present at the Canaccord Genuity Growth Conference on August 10th
-
ORBCOMM CFO to Present at Canaccord Genuity 36th Annual Growth Conference
-
ePlus to Present at the Canaccord Genuity 36th Annual Growth Conference
-
iRobot CEO to Speak at the Canaccord Genuity Annual Growth Conference
-
Blueprint Medicines to Present at Upcoming Investor Conferences in August
-
Sequential Brands Group to Present at Canaccord Genuity Growth Conference
-
Karyopharm to Present at Upcoming Investor Conferences
-
Apricus Biosciences to Present at the Canaccord Genuity 36th Annual Growth Conference
-
Zynerba Pharmaceuticals to Present at Canaccord Genuity’s 36th Annual Growth Conference


